Biocryst Pharmaceuticals buy Evercore Inc.
Start price
18.02.26
/
50%
€6.00
Target price
18.02.27
€14.35
Performance (%)
35.53%
Price
16.03.26
€8.13
Summary
This prediction is currently active. With a performance of 35.53% the BUY prediction by Evercore_Inc_ is a big success. This prediction currently runs until 18.02.27. The prediction end date can be changed by Evercore_Inc_ at any time. Evercore_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biocryst Pharmaceuticals | 9.448% |
| iShares Core DAX® | -1.104% |
| iShares Nasdaq 100 | 0.328% |
| iShares Nikkei 225® | -1.082% |
| iShares S&P 500 | -0.055% |
Comments by Evercore_Inc_ for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat